Stem Cell Reports · 2019 · 53 citations · 34 references
MedicineCardiologyPharmacologyCell SignalingCellular PharmacologySignal TransductionAtrial ElectrophysiologyAtrial FibrillationCardiac Ion ChannelsCardiac PharmacotherapyReceptor Tyrosine Kinase SignalingTyrosine Kinase InhibitorsBruton Tyrosine KinaseBruton's Tyrosine Kinase InhibitorsBtk InhibitorsCardiotoxicityReceptor Tyrosine Kinase CascadesStem Cell-derived CardiomyocytesTyrosine Kinase InhibitionTyrosine Kinase Inhibitor Cardiotoxicity
Ibrutinib (IB) is an oral Bruton's tyrosine kinase (BTK) inhibitor that has demonstrated benefit in B cell cancers, but is associated with a dramatic increase in atrial fibrillation (AF). We employed cell-specific differentiation protocols and optical mapping to investigate the effects of IB and other tyrosine kinase inhibitors (TKIs) on the voltage and calcium transients of atrial and ventricular human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs). IB demonstrated direct cell-specific effects on atrial hPSC-CMs that would be predicted to predispose to AF. Second-generation BTK inhibitors did not have the same effect. Furthermore, IB exposure was associated with differential chamber-specific regulation of a number of regulatory pathways including the receptor tyrosine kinase pathway, which may be implicated in the pathogenesis of AF. Our study is the first to demonstrate cell-type-specific toxicity in hPSC-derived atrial and ventricular cardiomyocytes, which reliably reproduces the clinical cardiotoxicity observed.
34
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
Jan A. Burger, Alessandra Tedeschi, Paul M. Barr et al. · New England Journal of Medicine · 2015 · 1.6K citations · Full text
Medicine, Oncology, Pharmacotherapy +11
Lee Honigberg, Ashley M. Smith, Mint Sirisawad et al. · Proceedings of the National Academy of Sciences · 2010 · 1.5K citations · Full text
Patient-Specific Induced Pluripotent Stem-Cell Models for Long-QT Syndrome
Alessandra Moretti, Milena Bellin, Andrea Welling et al. · New England Journal of Medicine · 2010 · 1.2K citations · Full text
Medicine, Cardiology, Genetics +17
Ibrutinib in Previously Treated Waldenström’s Macroglobulinemia
Steven P. Treon, Christina Tripsas, Kirsten Meid et al. · New England Journal of Medicine · 2015 · 931 citations · Full text